GONIX Performance — Gotham Neutral Fund, Institutional Class
Data updated: 2026-08-21
GONIX returned −3.61% year to date and −3.48% over one year to Jun 2026. Annualised returns are +8.89% over 3 years and +9.51% over 5 years. The fund trailed its US Multi-Cap Value category average: $100 invested three years ago grew to $129, against $142 for the category, and to $97 over one year, against $112. Volatility over the past three years was 6.05% a year. In the 12 months to Jun 2026 the fund lost a net $5.3M, and assets reached $105.87M.
GONIX Growth of $100
What $100 invested in Gotham Neutral Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Value category average over the same months.
| Period | GONIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $97 | $112 |
| 3 years (Jul 2023 – Jun 2026) | $129 | $142 |
| 5 years (Jul 2021 – Jun 2026) | $158 | $143 |
| Since data start (Jul 2019 – Jun 2026) | $143 | $188 |
GONIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −3.61% |
| 1 year | −3.48% |
| 3 years (annualised) | +8.89% |
| 5 years (annualised) | +9.51% |
GONIX Annual Returns
Calendar-year total returns of Gotham Neutral Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −3.61% |
| 2025 | +7.13% |
| 2024 | +17.69% |
| 2023 | +10.08% |
| 2022 | +6.61% |
| 2021 | +19.26% |
| 2020 | −16.48% |
| 2019 (Jul–Dec) | +0.78% |
GONIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.6% | +0.2% | +0.3% | −1.9% | +0.7% | −1.3% | — | — | — | — | — | — |
| 2025 | +1.8% | −0.5% | +0.2% | −0.1% | +3.8% | +1.6% | −3.1% | 0.0% | +1.5% | −0.3% | +1.9% | +0.3% |
| 2024 | +5.5% | +2.6% | +2.3% | −0.7% | +0.1% | +1.1% | +2.7% | +3.1% | +2.5% | −0.6% | −0.6% | −1.4% |
| 2023 | −2.1% | 0.0% | +2.2% | −0.3% | +1.6% | +2.3% | +1.5% | +1.1% | +1.6% | +1.2% | +1.6% | −0.8% |
| 2022 | +1.8% | −2.2% | +1.7% | +1.4% | +1.3% | −2.6% | +3.0% | −1.8% | −0.6% | +2.7% | +4.0% | −1.9% |
| 2021 | +1.4% | −0.2% | +4.4% | +1.7% | +2.1% | −1.5% | +0.3% | +1.7% | −0.8% | +0.9% | +4.0% | +3.9% |
| 2020 | −2.4% | −4.2% | −1.1% | −1.6% | −0.5% | 0.0% | +2.1% | −2.1% | −0.3% | −3.9% | −1.6% | −2.0% |
| 2019 | — | — | — | — | — | — | +1.5% | −1.0% | +1.8% | +0.8% | 0.0% | −2.2% |
GONIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 6.05%
- 3-year Sharpe ratio: 0.73 (vs 4.5% risk-free rate)
- Best month: +5.54% (Jan 2024)
- Worst month: −3.13% (Jul 2025)
GONIX Fund Flows
Monthly money in and out of Gotham Neutral Fund, from SEC Form N-PORT.
- 12-month net flow: −$5.3M
- 12-month gross sales (incl. reinvestments): $17.2M
- Sales ÷ redemptions: 0.76×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $404K | $2.2M | −$1.8M |
| May 2026 | $1.2M | $508K | $701K |
| Apr 2026 | $1.3M | $2.2M | −$903K |
| Mar 2026 | $1.9M | $2.6M | −$797K |
| Feb 2026 | $1.7M | $1.2M | $493K |
| Jan 2026 | $3.9M | $2.7M | $1.2M |
| Dec 2025 | $1.0M | $1.7M | −$706K |
| Nov 2025 | $1.2M | $996K | $216K |
| Oct 2025 | $951K | $939K | $12K |
| Sep 2025 | $1.4M | $1.2M | $282K |
| Aug 2025 | $516K | $3.5M | −$2.9M |
| Jul 2025 | $1.6M | $2.7M | −$1.1M |
GONIX Assets Under Management
Net assets of Gotham Neutral Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $105.87M |
| 2026-03-31 | $110.55M |
| 2025-12-31 | $110.95M |
| 2025-09-30 | $109.57M |
| 2025-06-30 | $115.24M |
| 2025-03-31 | $110.78M |
| 2024-12-31 | $96.13M |
| 2024-09-30 | $93.09M |
| 2024-06-28 | $82.32M |
| 2024-03-28 | $76.39M |
| 2023-12-29 | $66.42M |
| 2023-09-29 | $64.84M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.